Publication of Clinical Trials Data: A New Approach to Transparency in the European Legislative Framework
The European legislative framework is quickly moving towards transparency of the clinical trials data. The European Medicines Agency (EMA)'s Policy/0070, entered into force on January 1, 2015, marked a complete change of approach, moving from a reactive access, upon any interested parties'...
Main Author: | Elisa Stefanini |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Medicine Access @ Point of Care |
Online Access: | https://doi.org/10.5301/maapoc.0000018 |
Similar Items
-
Legislation for trial registration and data transparency
by: Wu Tai-Xiang, et al.
Published: (2010-05-01) -
The Evolution of European Union Legislative Framework Regarding Public Health
by: Liliana Lacramioara Pavel
Published: (2015-05-01) -
The relevance of the European regulations regarding the improvement of transparency and integrity in local public administration. Analysis of the implications on the legislation
by: Mihai Cristian APOSTOLACHE
Published: (2015-06-01) -
LEGISLATIVE FRAMEWORK OF BROADCASTING IN ROMANIA AND IN THE EUROPEAN UNION
by: Diana Prihoanca, et al.
Published: (2014-07-01) -
Transparency in clinical trials
by: Miguel Araujo Alonso
Published: (2013-04-01)